OXALIPLATINA 50 MG PO LIOF P/ SOL INJ IV CT FA VD AMB X 50 ML
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1101302370013 -
GGREM
521903702155114 -
Código de barras
7897473202061
O que a fonte publica
- Detentor do registro
- GLENMARK FARMACÊUTICA LTDA
- Princípios ativos
- OXALIPLATINA
- Embalagem
- 50 MG PO LIOF P/ SOL INJ IV CT FA VD AMB X 50 ML
- Tipo de produto
- Genérico
- Classe terapêutica
- L1F - COMPOSTOS ANTINEOPLÁSICOS DE PLATINA
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "OXALIPLATINA 50 MG PO LIOF P/ SOL INJ IV CT FA VD AMB X 50 ML",
"holder": "GLENMARK FARMACÊUTICA LTDA",
"stripe": null,
"barcodes": [
"7897473202061"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "521903702155114",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "44.363.661/0001-57",
"priceRegime": "Regulado",
"productName": "OXALIPLATINA",
"productType": "Genérico",
"hospitalOnly": true,
"presentation": "50 MG PO LIOF P/ SOL INJ IV CT FA VD AMB X 50 ML",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "1513.33",
"icms-12": "1719.69",
"icms-17": "1823.29",
"icms-18": "1845.52",
"icms-19": "1868.31",
"icms-20": "1891.66",
"icms-21": "1915.61",
"icms-22": "1940.17",
"icms-23": "1965.36",
"icms-17.5": "1834.34",
"icms-19.5": "1879.91",
"icms-20.5": "1903.56",
"icms-22.5": "1952.68",
"icms-12-alc": "1699.06",
"icms-17-alc": "1801.41",
"icms-18-alc": "1823.38",
"icms-19-alc": "1845.89",
"icms-20-alc": "1868.96",
"icms-21-alc": "1892.62",
"icms-22-alc": "1916.88",
"icms-23-alc": "1941.78",
"withoutTaxes": "1495.17",
"icms-17.5-alc": "1812.33",
"icms-19.5-alc": "1857.35",
"icms-20.5-alc": "1880.72",
"icms-22.5-alc": "1929.25"
},
"pisCofinsList": "Positiva",
"substanceText": "OXALIPLATINA",
"targetSpecies": [],
"consumerPrices": null,
"invalidBarcodes": [],
"activeSubstances": [
"OXALIPLATINA"
],
"therapeuticClass": "L1F - COMPOSTOS ANTINEOPLÁSICOS DE PLATINA",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1101302370013",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "L1F",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:521903702155114"